Company Filing History:
Years Active: 2005-2011
Title: The Innovative Contributions of Donald Geer
Introduction
Donald Geer is a notable inventor based in Queensbury, NY (US), recognized for his significant contributions to medical device technology. With a total of 2 patents, Geer has developed innovative solutions that enhance vascular access and blood treatment procedures.
Latest Patents
One of Geer's latest patents is the "Implantable Catheter Port." This invention features a single or multi-port vascular access device that includes one or more reservoirs, each covered by a needle-penetrable, self-sealing septum. The design ensures that fluid movement into and out of the needle is unimpeded, maximizing flow and minimizing regions of low fluid flow that could lead to coagulation or cell shearing. The unique tapered and tangential geometries of the fluid passage enhance the efficiency of the device.
Another significant patent is the "Blood Treatment Catheter and Method." This invention presents various embodiments of a hemo-dialysis catheter, where the aspirating port is positioned distal to the infusion ports. The circumferential arrangement of the infusion ports allows for a 360° jet of fluid, effectively abrading occlusive material that could block the ports. This innovative design prevents occlusion growth, ensuring the aspirating port remains functional.
Career Highlights
Throughout his career, Donald Geer has worked with reputable companies such as Angiodynamics, Inc. and R4 Vascular, Inc. His experience in these organizations has contributed to his expertise in developing advanced medical devices.
Collaborations
Geer has collaborated with notable individuals in the field, including Melvin Rosenblatt and William M Appling. These partnerships have likely fostered innovation and the exchange of ideas in medical technology.
Conclusion
Donald Geer's contributions to the field of medical devices, particularly through his patents, demonstrate his commitment to improving patient care. His innovative designs in vascular access and blood treatment continue to influence the industry positively.